期刊
AMYOTROPHIC LATERAL SCLEROSIS
卷 9, 期 1, 页码 43-49出版社
INFORMA HEALTHCARE
DOI: 10.1080/17482960701737716
关键词
AS; MND; neuroimaging; executive function; PET; verbal fluency; confrontation naming
资金
- Medical Research Council [G108/585] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
- Medical Research Council [G0700704B] Funding Source: researchfish
- MRC [G108/585] Funding Source: UKRI
Amyotrophic lateral sclerosis (ALS) is a multi-system disorder. Mild cognitive deficits are present in a subgroup of non-demented patients with ALS. Detailed neuropsychological assessments reveal deficits of word retrieval including impairments on tests of verbal fluency and confrontation naming. The PET GABAA receptor ligand [C-11]-flumazenil is a marker of neuronal dysfunction in ALS. This study used [C-11]-flumazenil PET to identify correlations between cortical regions and impairments in word retrieval. Twelve patients with ALS underwent [C-11]-flumazenil PET and neuropsychological assessment, including tests of written letter fluency and confrontation naming. Poorer performance on verbal fluency correlated with decreased [C-11]-flumazenil binding in a region including the right inferior frontal gyrus, superior temporal gyrus, and anterior insula. Poorer performance on a test of confrontation naming correlated with decreased binding in the left middle frontal gyrus (extending to Broca's area) and left cuneus. This study indicates that [C-11]-flumazenil PET can be used to help localize cortical regions associated with cognitive deficits in ALS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据